WallStreetZenWallStreetZen

NASDAQ: FLGT
Fulgent Genetics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Fulgent Genetics earnings were -$60.5M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest FLGT earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$23.4M, up 254.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, FLGT reported annual earnings of -$60.5M, with 41.7% growth.

FLGT earnings history

Current Revenue
$322.7M
Current Earnings
-$60.5M
Current Profit Margin
-18.8%

FLGT Return on Equity

Current Company
-5.4%
Current Industry
-2.2%
Current Market
28.9%
FLGT's Return on Equity (-5.4%)... subscribe to Premium to read more.
High Return on Equity Performance

FLGT Return on Assets

Current Company
-5%
Current Industry
6.4%
FLGT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when FLGT announces earnings.

FLGT Return on Capital Employed

Current Company
-6.1%
Current Industry
13.3%
FLGT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FLGT vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
FLGT-$42.95M-$60.51MN/A-$1.97
MYGN-$323.20M-$365.90MN/A-$3.95
ACRS-$64.47M-$64.92MN/A-$0.53
LAB-$95.75M-$74.90MN/A-$0.20
PRE-$54.50M-$58.32MN/A-$4.15
View Top Diagnostic & Research Stocks

Fulgent Genetics Earnings Reports & History FAQ

What were Fulgent Genetics's earnings last quarter?

On FLGT's earnings call on Invalid Date, Fulgent Genetics (NASDAQ: FLGT) reported Q4 2025 earnings per share (EPS) of -$0.76, up 300% year over year. Total FLGT earnings for the quarter were -$23.42 million. In the same quarter last year, Fulgent Genetics's earnings per share (EPS) was -$0.19.

If you're new to stock investing, here's how to buy Fulgent Genetics stock.

Is Fulgent Genetics profitable or losing money?

As of the last Fulgent Genetics earnings report, Fulgent Genetics is currently losing money. Fulgent Genetics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$60.51 million, a 41.69% increase year over year.

What was FLGT's earnings growth in the past year?

As of Fulgent Genetics's earnings date in Invalid Date, Fulgent Genetics's earnings has grown year over year. FLGT earnings in the past year totalled -$60.51 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.